Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R William Watson

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Prostate|March 25, 2019
Expression of tSTAT3, pSTAT3<sup>727</sup> , and pSTAT3 <sup>705</sup> in the epithelial cells of hormone-naïve prostate cancerAgnieszka Krzyzanowska, Nicholas Don-Doncow, Felicia Elena Marginean, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 3, 2007
Can preoperative modelling of individual neutrophil adhesion responses predict renal morbidity?David G Healy, Alfred E Wood, Amanda O'Neill, et al.
The Prostate|March 15, 2012
The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancerSheng F Oon, Deirdre M Fanning, Yue Fan, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Labor induces a maternal inflammatory response syndromeEleanor J Molloy, Amanda J O'neill, Julie J Grantham, et al.
Molecular Oncology|January 31, 2017
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancerKaren Hanrahan, Amanda O'Neill, Maria Prencipe, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Oncotarget|October 1, 2016
Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potentialEamon P Mulvaney, Christine Shilling, Sarah B Eivers, et al.
International Journal of Molecular Sciences|December 8, 2020
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan ProfilingSarah Gilgunn, Keefe Murphy, Henning Stöckmann, et al.
The Prostate|August 8, 2015
Relationship between serum response factor and androgen receptor in prostate cancerMaria Prencipe, Amanda O'Neill, Gillian O'Hurley, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 9, 2016
Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivoJames C Evans, Meenakshi Malhotra, Jianfeng Guo, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Prostate|March 25, 2019
Expression of tSTAT3, pSTAT3<sup>727</sup> , and pSTAT3 <sup>705</sup> in the epithelial cells of hormone-naïve prostate cancerAgnieszka Krzyzanowska, Nicholas Don-Doncow, Felicia Elena Marginean, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 3, 2007
Can preoperative modelling of individual neutrophil adhesion responses predict renal morbidity?David G Healy, Alfred E Wood, Amanda O'Neill, et al.
The Prostate|March 15, 2012
The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancerSheng F Oon, Deirdre M Fanning, Yue Fan, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Labor induces a maternal inflammatory response syndromeEleanor J Molloy, Amanda J O'neill, Julie J Grantham, et al.
Molecular Oncology|January 31, 2017
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancerKaren Hanrahan, Amanda O'Neill, Maria Prencipe, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Oncotarget|October 1, 2016
Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potentialEamon P Mulvaney, Christine Shilling, Sarah B Eivers, et al.
International Journal of Molecular Sciences|December 8, 2020
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan ProfilingSarah Gilgunn, Keefe Murphy, Henning Stöckmann, et al.
The Prostate|August 8, 2015
Relationship between serum response factor and androgen receptor in prostate cancerMaria Prencipe, Amanda O'Neill, Gillian O'Hurley, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 9, 2016
Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivoJames C Evans, Meenakshi Malhotra, Jianfeng Guo, et al.
Pageof 4